Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials

Medicine and Dentistry

• Age Related Macular Degeneration 100%
• Arm 15%
• Autofluorescence 15%
• Biological Marker 15%
• Choroidal Neovascularization 7%
• Controlled Clinical Trial 7%
• Endophthalmitis 7%
• Geographic Atrophy 100%
• Intention-to-Treat Analysis 7%
• Randomized Clinical Trial 100%
• Sham Procedure 23%

Biochemistry, Genetics and Molecular Biology

• Controlled Clinical Trial 50%
• Randomized Clinical Trial 100%
• Subretinal Neovascularization 50%

Neuroscience

• Age-Related Macular Degeneration 100%
• Alginic Acid 7%
• Autofluorescence 15%
• Choroidal Neovascularization 7%
• Endophthalmitis 7%